BioCryst Pharmaceuticals, Inc.
CRYSTALLINE SALTS OF A PLASMA KALLIKREIN INHIBITOR
Last updated:
Abstract:
Disclosed are crystalline salts of Compound I, methods of preparing them, and related pharmaceutical preparations thereof. Also disclosed are methods of treatment using the crystalline salts of the invention. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
2 Sep 2021
Issue date:
30 Jun 2022